|
RPP30 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.120200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.176400E-03 |
| Normal-vs-Stage2 |
2.860200E-01 |
| Normal-vs-Stage3 |
8.653600E-01 |
| Normal-vs-Stage4 |
3.040600E-01 |
| Stage1-vs-Stage2 |
5.768400E-01 |
| Stage1-vs-Stage3 |
2.759400E-03 |
| Stage1-vs-Stage4 |
2.171200E-01 |
| Stage2-vs-Stage3 |
2.377800E-01 |
| Stage2-vs-Stage4 |
7.728800E-01 |
| Stage3-vs-Stage4 |
2.293800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.946100E-02 |
| Normal-vs-AfricanAmerican |
7.891800E-02 |
| Normal-vs-Asian |
5.686600E-01 |
| Caucasian-vs-AfricanAmerican |
4.456800E-01 |
| Caucasian-vs-Asian |
9.438000E-01 |
| AfricanAmerican-vs-Asian |
7.225200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.012000E-01 |
| Normal-vs-Female |
7.180200E-03 |
| Male-vs-Female |
6.300500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.633600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.334200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.461620E-01 |
| Normal-vs-Age(81-100Yrs) |
6.366000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.548400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.059380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.804830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.455000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.137600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.531600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.221500E-04 |
| Normal-vs-Grade 2 |
1.977180E-03 |
| Normal-vs-Grade 3 |
6.031800E-01 |
| Normal-vs-Grade 4 |
8.708200E-01 |
| Grade 1-vs-Grade 2 |
9.412100E-02 |
| Grade 1-vs-Grade 3 |
1.238370E-03 |
| Grade 1-vs-Grade 4 |
5.315400E-03 |
| Grade 2-vs-Grade 3 |
1.979460E-03 |
| Grade 2-vs-Grade 4 |
8.940500E-03 |
| Grade 3-vs-Grade 4 |
5.405800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.099900E-03 |
| Normal-vs-ccB subtype |
7.003400E-01 |
| ccA subtype-vs-ccB subtype |
1.081590E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.037800E-02 |
| Normal-vs-N1 |
7.994400E-01 |
| N0-vs-N1 |
4.932000E-01 |
|
|
